Lumida
/VOYA
⌘K
Voya Financial Inc

Voya Financial Inc

VOYA
$103.41USD+0.72%+0.74 today

MARKET CAP

9.4B

P/E (TTM)

16.4x

FWD P/E

DAY RANGE

$102 – $104

52W RANGE

$65
$106

The case for & against

Bull & Bear analysis

Bullish

Voya Financial, Inc. (NYSE: VOYA) is a prominent player in the financial services sector, focusing on retirement, investment management, and employee benefits. Positioned strategically in the retirement solutions market, Voya serves millions of customers and is committed to providing effective workplace savings solutions. With a robust service offering that includes defined contribution plans and wealth management, Voya is well-suited to capitalize on the growing awareness of financial planning among consumers, thereby enhancing its market presence and competitive advantage.

Bull says

  • Q2 defined contribution net inflows exceeded $8B, driving fee-based revenue growth.
  • Generated ~$150M of excess capital in Q2 with cash conversion above 100%.
  • Wealth management revenue rose ~12% YoY, expanding growth runway.
  • Severance-driven cost cuts target margin uplift by 2027.
  • Returned ~$200M via dividends and buybacks, highlighting shareholder focus.
  • High earnings yield and strong leverage position support valuation.

Bear says

  • Profitability metrics weakened by Q2 alternative investment performance issues.
  • Q2 2026 EPS consensus cut to $9.35 from $9.45, signaling earnings pressure.
  • Alternative investments drove negative margin impacts, increasing volatility.
  • Activist investor scrutiny adds governance uncertainty and strategic risks.
  • Regulatory shifts could elevate compliance costs and limit product agility.
  • Weak profitability and low dividend yield weigh on income-oriented investors.

Investment themes with VOYA

High Dividend Yield -0.51%

Companies paying above-average dividends

AVGO · JPM · XOM

Earnings Call · Q4 2023 · Mgmt. Guidance

Updated 02-06-2025bullish

Transcript signals

Bull points

  • For 2023, we generated $7.02 per share of adjusted operating earnings including $1.63 in the fourth quarter. These results reflected a record year in Health Solutions.
  • Looking ahead into 2024, we are reaffirming our EPS CAGR target of 12% to 17% for the three year period ending in 2024.
  • Our longer term outlook is for annual EPS growth that exceeds 10% beginning in 2025.

Bear points

  • Although the fourth quarter was affected by elevated voluntary claims, our aggregate loss ratio remained well within expectations.
  • Fourth quarter results were also affected by flows and investment management that were weaker than anticipated as broader industry headwinds continued.
Read full transcript analysis ›